Purchase PT141 Magnus Pharmaceutical
PT-141, or bremelanotide, belongs to the new class of synthetic proteins that act as melanocortin agonists. It is a peptide compound under the new drug development process known as palatal technology. Its molecular formula is C50H68N14O10; its molecular weight / mass is 1025.2.
This new representative peptide was recently synthesized from melanotan-peptide, and so far participates in a few clinical trials with animal models in different countries. To date, the largest randomized controlled trials have been conducted in 2004 and 2007 by examining the safety evaluation, pharmacokinetic and pharmacodynamic characteristics of males and females, respectively. By the end of 2012, the second phase of the clinical trial was complete and its results will be published soon.
The main characteristic of PT-141 is to have a positive influence on systemic sexual dysfunction. Unlike other compounds and hormones, bremelanotide does not affect the vascular system; instead, this research compound works by stimulating melanocortin receptors, which in turn leads to sexual stimulation and modulation of inflammation.
The dosage of PT 141 Bremelanotide Peptide Magnus Pharmaceuticals:
The recommended dose for optimum results is 0.5 to 2 mg 2-4 hours before the desired effect, similar to Viagra.
Possible side effects of PT 141 Bremelanotide Peptide Magnus Pharmaceuticals:
The peptide PT 141 Bremelanotide by Magnus Pharmaceuticals aims to boost libido. Without causing any damaging effects on the blood vessels, there are usually no side effects when using this peptide. However, more frequent hunger attacks are reported.